CHICAGO: Young women undergoing chemotherapy for certain types of breast cancer may be able to preserve their fertility by adding the drug goserelin to their treatment, researchers said Friday.
The cancer drug also appeared to improve survival, according to the results of a phase III clinical trial unveiled at the American Society for Clinical Oncology annual meeting.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.